Keywords: عدم تحمل استاتین; PCSK9 inhibitor; Alirocumab; Expanded use; Heterozygous familial hypercholesterolemia; Coronary heart disease; LDL-C; Statin intolerance; ODYSSEY;
مقالات ISI عدم تحمل استاتین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: عدم تحمل استاتین; Cardiovascular disease; Hyperlipidemia; ETC-1002; Low-density lipoprotein cholesterol; Prevention; Statin-associated muscle symptoms; Statin intolerance;
Keywords: عدم تحمل استاتین; HMG-CoA reductase inhibitors (statins); Statin intolerance; Muscle pain; Muscle weakness; Myalgia;
Keywords: عدم تحمل استاتین; Statins; Statin intolerance; Myopathy; Ezetimibe; Bile acid sequestrants; PCSK9 inhibitors; Lipoprotein apheresis;
Keywords: عدم تحمل استاتین; Cholesterol; Statin; 10-year risk; Cardiovascular disease; Lipids; Statin intolerance;
Keywords: عدم تحمل استاتین; Statin intolerance; Health care costs; LDL-C; High CV risk; Integrated health system;
Keywords: عدم تحمل استاتین; cardiovascular disease; low-density lipoprotein; myalgia; myopathy; statin intolerance; AHA; American Heart Association; ACC; American College of Cardiology; ASCVD; atherosclerotic cardiovascular disease; CI; confidence interval; CK; creatinine kinase; HR
Keywords: عدم تحمل استاتین; Myalgia; Myopathy; Musculoskeletal symptoms; Rhabdomyolysis; Statin intolerance; Statins; Lipids;
Keywords: عدم تحمل استاتین; Hypercholesterolemia; Statin; Statin intolerance; Statin-associated symptoms;
Keywords: عدم تحمل استاتین; Statin intolerance; Nocebo; Muscle; Statin adverse effects; Rechallenge; PCSK9 inhibitor; Blinding techniques; Internet; Social media; Iatrogenic;
Keywords: عدم تحمل استاتین; administrative data; cardiovascular risk; claims data; electronic medical record; hypercholesterolemia; statin intolerance; validation;
Keywords: عدم تحمل استاتین; Statin; Statin intolerance; Adverse events; Myopathy; Myalgia; Cognitive effects;
Keywords: عدم تحمل استاتین; Metabolic syndrome; Insulin resistance; HMG CoA reductase inhibitors (statins); Statin intolerance; Muscle pain; Muscle weakness;
Keywords: عدم تحمل استاتین; Statin intolerance; Myalgias; Myopathy; PCSK9 inhibitors; ACC/AHA; American College of Cardiology/American Heart Association; ASCVD; Atherosclerotic cardiovascular disease; CoQ10; Coenzyme Q 10; CK; Creatine Kinase; FDA; Federal Drug Administration; HMG-C
Keywords: عدم تحمل استاتین; LDL; Lipid metabolism; Cholesterol; Hypercholesterolemia; Dyslipidemia; ATP citrate lyase; AMPK; ETC-1002; Statin intolerance;
Keywords: عدم تحمل استاتین; HMG-COA reductase inhibitors; Statins Hypothyroidism; Statin intolerance; Dyslipidemia; Subclinical hypothyroidism; Statin rechallenge; Epidemiology;
Keywords: عدم تحمل استاتین; Statins; HMG-CoA reductase inhibitors; Drug-related side effects; Statin intolerance; Myotoxicity; MyopathyEstatinas; Inhibidores de la HMG-CoA reductasa; Efectos secundarios a fármacos; Intolerancia a estatinas; Miotoxicidad; Miopatía
Keywords: عدم تحمل استاتین; Statins; HMG-CoA reductase inhibitors; Drug-related side effects; Statin intolerance; Myotoxicity; MyopathyEstatinas; Inhibidores de la HMG-CoA reductasa; Efectos secundarios a fármacos; Intolerancia a estatinas; Miotoxicidad; Miopatía
PCSK9 inhibitors in clinical practice: Delivering on the promise?
Keywords: عدم تحمل استاتین; PCSK9 inhibitors; Familial hypercholesterolemia; Statin intolerance; Hypercholesterolemia; Lipid-lowering drugs;
Bempedoic Acid (ETC-1002)
Keywords: عدم تحمل استاتین; Bempedoic acid; Cholesterol; Cardiovascular disease; Lipids; Lipid-lowering agents; Statin intolerance; Nonstatin therapy;
Utilization Patterns of Lipid-lowering Therapies in Patients With Atherosclerotic Cardiovascular Disease or Diabetes: A Population-based Study in South Korea
Keywords: عدم تحمل استاتین; adherence; atherosclerotic cardiovascular disease; diabetes; statin; statin intolerance; treatment pattern;
The Role of Nutraceuticals in Statin Intolerant Patients
Keywords: عدم تحمل استاتین; cardiovascular risk; dyslipidemia; nutraceuticals; position paper; statin intolerance; CVD; cardiovascular disease; HDL-C; high-density lipoprotein cholesterol; HMG-CoA; hydroxymethylglutaryl coenzyme A; ILEP; International Lipid Expert Panel; LDL-C; low-
Statin associated myopathy in clinical practice. Results of DAMA study
Keywords: عدم تحمل استاتین; Statins; Statin intolerance; Myalgia; Myopathy; Myositis; Muscle symptoms; Estatinas; Intolerancia a estatinas; Mialgia; MiopatÃa; Miositis; SÃntomas musculares;
Estudios clÃnicos con inhibidores de la PCSK9
Keywords: عدم تحمل استاتین; iPCSK9; Prevención secundaria; Hipercolesterolemia familiar; Intolerancia a estatinas; PCSK9 inhibitors; Secondary prevention; Familial hypercholesterolemia; Statin intolerance;
MiopatÃa asociada al uso de estatinas en la práctica clÃnica. Resultados del estudio DAMA
Keywords: عدم تحمل استاتین; Estatinas; Intolerancia a estatinas; Mialgia; MiopatÃa; Miositis; SÃntomas musculares; Statins; Statin intolerance; Myalgia; Myopathy; Myositis; Muscle symptoms;
Update on the use of PCSK9 inhibitors in adults: Recommendations from an Expert Panel of the National Lipid Association
Keywords: عدم تحمل استاتین; PCSK9 inhibitors; Evolocumab; Alirocumab; Dyslipidemia; Hypercholesterolemia; Familial hypercholesterolemia; Statin intolerance; Lipid treatment guidelines;
Practical aspects in the management of statin-associated muscle symptoms (SAMS)
Keywords: عدم تحمل استاتین; Statin; Muscle symptoms; Myalgia; Myopathy; Statin intolerance; Lipids; Cholesterol; Cardiovascular disease;
Gender differences in side effects and attitudes regarding statin use in the Understanding Statin Use in America and Gaps in Patient Education (USAGE) study
Keywords: عدم تحمل استاتین; Gender; Statins; Statin intolerance; Muscle pains; Myopathy; Compliance;
Treatment with ETC-1002 alone and in combination with ezetimibe lowers LDL cholesterol in hypercholesterolemic patients with or without statin intolerance
Keywords: عدم تحمل استاتین; ETC-1002; Ezetimibe; Hypercholesterolemia; Myalgia; Statin-associated muscle symptoms; Statin intolerance;
Analysis of vitamin D levels in patients with and without statin-associated myalgia — A systematic review and meta-analysis of 7 studies with 2420 patients
Keywords: عدم تحمل استاتین; Myalgia; Statin-associated myalgia; Statin intolerance; Vitamin D
Vitamin D status modifies the association between statin use and musculoskeletal pain: A population based study
Keywords: عدم تحمل استاتین; Statins; HMG-CoA reductase inhibitors; Vitamin D; 25-Hydroxyvitamin D; Myalgia; Muscle symptoms; Statin intolerance;
Use of ETC-1002 to treat hypercholesterolemia in patients with statin intolerance
Keywords: عدم تحمل استاتین; LDL-cholesterol; Statin intolerance; ETC-1002; Muscle complaints; Hypercholesterolemia;
NLA Task Force on Statin Safety - 2014 update
Keywords: عدم تحمل استاتین; Statins; Statin drug; Statin muscle; Statin intolerance; Statin brain; Statin liver; Statin diabetes;
Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: Design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial
Keywords: عدم تحمل استاتین; Alirocumab; Ezetimibe; Hypercholesterolemia; PCSK9; Phase 3 clinical trial; Statin intolerance; Muscle symptoms; Statin myopathy;
Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance: The GAUSS-2 Randomized, Placebo-Controlled Phase 3 Clinical Trial of Evolocumab
Keywords: عدم تحمل استاتین; evolocumab; ezetimibe; hypercholesterolemia; LDL-cholesterol; statin intolerance; CHD; coronary heart disease; CI; confidence interval; CK; creatine kinase; HDL-C; high-density lipoprotein cholesterol; LDL-C; low-density lipoprotein cholesterol; LDLR; low
An assessment by the Statin Muscle Safety Task Force: 2014 update
Keywords: عدم تحمل استاتین; Muscle adverse events; Myalgia; Myopathy; Neuromuscular testing; Rhabdomyolysis; Statin intolerance; Statins
The tolerability and efficacy of low-dose simvastatin in statin-intolerant patients
Keywords: عدم تحمل استاتین; Statin intolerance; Low-dose statin; Simvastatin; LDL-cholesterol; Cardiovascular prevention